1. Home
  2. PBLS vs TENB Comparison

PBLS vs TENB Comparison

Compare PBLS & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.81

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo Tenable Holdings Inc.

TENB

Tenable Holdings Inc.

HOLD

Current Price

$39.54

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBLS
TENB
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
PBLS
TENB
Price
$28.81
$39.54
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
$31.69
AVG Volume (30 Days)
545.1K
3.6M
Earning Date
N/A
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.23
EPS
N/A
0.01
Revenue
N/A
$999,405,000.00
Revenue This Year
N/A
$9.37
Revenue Next Year
N/A
$7.04
P/E Ratio
N/A
$3,991.00
Revenue Growth
N/A
11.04
52 Week Low
$25.56
$15.73
52 Week High
$33.65
$43.67

Technical Indicators

Market Signals
Indicator
PBLS
TENB
Relative Strength Index (RSI) 52.17 63.56
Support Level $26.96 $25.61
Resistance Level $30.90 N/A
Average True Range (ATR) 2.39 2.91
MACD -0.05 -0.05
Stochastic Oscillator 30.56 68.88

Price Performance

Historical Comparison
PBLS
TENB

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: